Citations

Clear

4847 citation(s) found for "Tu, Eric".

Multi-Institutional Analysis of Robotic Radical Cystectomy for Bladder Cancer: Perioperative Outcomes and Complications in 227 Patients
Smith, Angela B. , Raynor, Mathew, Amling, Christopher L. , Busby, J. Erik, Castle, Erik P., Davis, Rodney , Nielsen, Matthew E. , Thomas, Raju , Wallen, Eric, Woods, Michael, Pruthi, Raj S.

Mayo Clinic

Journal of Laparoendoscopic & Advanced Surgical Techniques | December 5, 2011 | Volume: 22 | Issue: 1 | Pages: 17-21

10.1089/lap.2011.0326 | PMID 22142028 Get It

Surgeon radiation exposure in cone beam computed tomography‐based, image‐guided spinal surgery
Nottmeier, Eric W. , Bowman, Cammi, Nelson, Kevin L.

Mayo Clinic

The International Journal of Medical Robotics and Computer Assisted Surgery | November 24, 2011 | Volume: 8 | Issue: 2 | Pages: 196-200

10.1002/rcs.450 | PMID 22114012 Get It

AbstractBackgroundRadiation exposure to the surgeon is a concern in spinal surgery, especially with the increasing popularity of minimally invasive spinal surgery techniques. Three‐dimensional (3D) image guidance used in conjunction with cone beam computed tomography (cbCT) has a theoretical advantage of decreased radiation exposure to the surgeon and operating room (OR) staff. Radiation scatter to the environment immediately surrounding a CT scanner during acquisition of a CT scan is a known entity. This in vivo study measures the radiation exposure to the surgeon when using cbCT registration in 3D image‐guided spinal surgery.MethodsTwo badge dosimeters were worn by the surgeon (EWN), one on the right waistband of the surgeon's scrubs and the other located over the thyroid area during 25 consecutive spinal surgery cases in which cbCT was used in conjunction with 3D image guidance. No lead protection was worn by the surgeon. The cbCT device was used for registration of the anatomy and to confirm adequate instrumentation placement. The surgeon stood behind a clear lead shield in the same location during every spin of the cbCT device. After the 25th case, the badge dosimeters were sent to the radiology department for analysis.ResultsOverall, 63 cbCT spins were accomplished in 25 patients. A total of 228 screws were placed into spinal levels spanning from C2 to the ileum. No complications resulted from instrumentation placement or the use of image guidance.Analysis of both badge dosimeters revealed 0 millirem (mRem) exposure.ConclusionsOur study demonstrates that no radiation exposure to the surgeon occurs in cbCT‐based, 3D image‐guided spinal surgery procedures. Additionally, radiation scatter does not result in surgeon radiation exposure during patient registration if the surgeon stands behind a lead shield 10 feet from the cbCT device and not in direct line with the opening of the cbCT tube. Copyright © 2011 John Wiley & Sons, Ltd.
Improvement in Academic Behaviors After Successful Treatment of Convergence Insufficiency
Borsting, Eric , Mitchell, G. Lynn , Kulp, Marjean Taylor , Scheiman, Mitchell , Amster, Deborah, Coulter, Rachael A., Fecho, Gregory, Gallaway, Michael, Granet, David B. , Hertle, Richard W. , Rodena, Jacqueline, Yamada, Tomohiko , Group, the CITT Study, Cotter, Susan A. , Yamada, Tomohiko, Group, the CITT Study

Mayo Clinic

Optometry and Vision Science | November 11, 2011 | Volume: 89 | Issue: 1 | Pages: 12-18

10.1097/opx.0b013e318238ffc3 | PMID 22080400 Get It

ABSTRACT Purpose. To determine whether treatment of symptomatic convergence insufficiency (CI) has an effect on Academic Behavior Survey (ABS) scores. Methods. The ABS is a six‐item survey developed by the Convergence Insufficiency Treatment Trial Group that quantifies the frequency of adverse school behaviors and parental concern about school performance on an ordinal scale from 0 (never) to 4 (always) with total scores ranging from 0 to 24. The ABS was administered at baseline and after 12 weeks of treatment to the parents of 218 children aged 9 to 17 years with symptomatic CI, who were enrolled in the Convergence Insufficiency Treatment Trial and randomized into (1) home‐based pencil push‐ups; (2) home‐based computer vergence/accommodative therapy and pencil push‐ups; (3) office‐based vergence/accommodative therapy with home reinforcement; and (4) office‐based placebo therapy with home reinforcement. Participants were classified as successful (n = 42), improved (n = 60), or non‐responder (n = 116) at the completion of 12 weeks of treatment using a composite measure of the symptom score, nearpoint of convergence, and positive fusional vergence. Analysis of covariance methods were used to compare the mean change in ABS between response to treatment groups while controlling for the ABS score at baseline. Results. The mean ABS score for the entire group at baseline was 12.85 (SD = 6.3). The mean ABS score decreased (improved) in those categorized as successful, improved, and non‐responder by 4.0, 2.9, and 1.3 points, respectively. The improvement in the ABS score was significantly related to treatment outcome (p < 0.0001), with the ABS score being significantly lower (better) for children who were successful or improved after treatment as compared to children who were non‐responders (p = 0.002 and 0.043, respectively). Conclusions. A successful or improved outcome after CI treatment was associated with a reduction in the frequency of adverse academic behaviors and parental concern associated with reading and school work as reported by parents.
Outcomes following surgery without radiotherapy for rectal cancer
Mathis, Kellie L. , Dozois, Eric J. , Huebner, Marianne , Haddock, Michael G. , Wolff, B. G., Nelson, Heidi , Pembérton, John H., Larson, David W. , Cima, Robert R.

Mayo Clinic

Journal of British Surgery | November 3, 2011 | Volume: 99 | Issue: 1 | Pages: 137-143

10.1002/bjs.7739 | PMID 22052336 Get It

Abstract Background This study determined survival and recurrence rates following curative resection of rectal cancer without radiotherapy. Methods This was a retrospective review of the Mayo Clinic database of patients with rectal cancer treated with curative intent using surgery alone from 1990 to 2006. Patients who received neoadjuvant chemotherapy or radiation therapy and those who had any postoperative radiotherapy were excluded. Details were collected from the database and patient records using a protocol approved by the institutional review board. Results Some 655 consecutive patients with rectal cancer treated with curative intent using surgery alone were identified; 397 had stage I disease, 125 stage II and 133 stage III. Four hundred and nine patients underwent anterior resection (AR) and 246 abdominoperineal resection (APR). Median follow-up was 62 months. The 5-year rate of local recurrence was 4·3 per cent, disease-free survival 90·0 per cent and cancer-specific survival 91·5 per cent. Stage-specific and all-stage disease-free survival did not differ significantly between AR and APR. The 5-year cumulative local recurrence rate was lower following AR than APR (3·6 versus 5·5 per cent; P = 0·321). There were only two patients with positive margins and type of operation was not significant on multivariable analysis. Conclusion Well-performed, standardized APRs have similar local recurrence to AR. Radiation therapy may not confer much additional benefit. Copyright © 2011 British Journal of Surgery Society Ltd. Published by John Wiley & Sons, Ltd.
Primary Snoring and Upper Airway Resistance Syndrome
Ramar, Kannan , Olson, Eric J.

Mayo Clinic

Contemporary Sleep Medicine For Patients | October 30, 2011 | Volume: No volume available | Issue: No issue available | Pages: 18-20

10.2174/978160805267711101010018 Get It

Snoring is the sound of soft tissues vibrating within the upper throat during sleep. The vibration is a result of turbulent air flow through the throat as it narrows during sleep. Snoring is very common in adults and may occur alone or be a feature of other conditions characterized by greater throat narrowing during sleep, namely upper airway resistance syndrome (UARS) and obstructive sleep apnea syndrome (OSA). UARS is marked by daytime sleepiness and/or fatigue in the context of frequent respiratory-effort related arousals (RERAs). RERAs are episodic arousals that follow periods of more intense breathing effort as resistance to airflow in the throat increases. Once the throat is very narrow, hypopneas (partial reduction in airflow) and apneas (complete cessation of airflow) occur, and these events comprise OSA. Whether UARS is an entity distinct from OSA remains still debated. Risk factors for snoring and UARS are similar and include obesity, nasal congestion, alcohol and drug consumption before bed, and abnormalities of the bony and soft tissue structures of the head and neck. Snoring can be a nuisance, but generally does not produce daytime sequelae, while UARS may lead to daytime fatigue and sleepiness. Treatment options for snoring and UARS include risk factor modifications, nasal-directed therapies, oral appliances, upper airway surgery, while continuous positive airway pressure (CPAP) is an additional option for UARS.
Multi-institutional phase 2 clinical and pharmacogenomic trial of tipifarnib plus etoposide for elderly adults with newly diagnosed acute myelogenous leukemia
Karp, Judith E. , Vener, Tatiana, Raponi, Mitch , Ritchie, Ellen K. , Gore, Steven D. , Morris, Lawrence E. , Feldman, Eric J. , Greer, Jacqueline M., Malek, Sami N. , Ironside, Valerie, Galkin, Steven, McDevitt, Michael A. , Roboz, G., Gocke, Christopher D. , Derecho, Carlo, Palma, John F. , Wright, John J., Garret-Mayer, Elizabeth, Smith, Benjamin D. , Carraway, Hetty E. , Levis, Mark J. , Roboz, Gail J. , Wang, Yixin , Kaufmann, Scott H. , Wright, John J.

Mayo Clinic

Blood | October 15, 2011 | Volume: 119 | Issue: 1 | Pages: 55-63

10.1182/blood-2011-08-370825 | PMID 22001391 Get It

Abstract Tipifarnib (T) exhibits modest activity in elderly adults with newly diagnosed acute myelogenous leukemia (AML). Based on preclinical synergy, a phase 1 trial of T plus etoposide (E) yielded 25% complete remission (CR). We selected 2 comparable dose levels for a randomized phase 2 trial in 84 adults (age range, 70-90 years; median, 76 years) who were not candidates for conventional chemotherapy. Arm A (T 600 mg twice a day × 14 days, E 100 mg days 1-3 and 8-10) and arm B (T 400 mg twice a day × 14 days, E 200 mg days 1-3 and 8-10) yielded similar CR, but arm B had greater toxicity. Total CR was 25%, day 30 death rate 7%. A 2-gene signature of high RASGRP1 and low aprataxin (APTX) expression previously predicted for T response. Assays using blasts from a subset of 40 patients treated with T plus E on this study showed that AMLs with a RASGRP1/APTX ratio of more than 5.2 had a 78% CR rate and negative predictive value 87%. This ratio did not correlate with outcome in 41 patients treated with conventional chemotherapies. The next T-based clinical trials will test the ability of the 2-gene signature to enrich for T responders prospectively. This study is registered at www.clinicaltrials.gov as #NCT00602771.
Role of Haloperidol in Palliative Medicine
Prommer, Eric

Mayo Clinic

American Journal of Hospice and Palliative Medicine® | October 13, 2011 | Volume: 29 | Issue: 4 | Pages: 295-301

10.1177/1049909111423094 | PMID 21998445 Get It

Haloperidol is a butyrophenone neuroleptic agent characterized as a high-affinity dopamine antagonist, originally used for the treatment of schizophrenia. Awareness of the role dopamine plays in many symptoms in palliative care, such as nausea, vomiting, and delirium, has led to the use of dopamine antagonists such as haloperidol for the treatment of these symptoms in the palliative care setting. Listed as 1 of the 25 important drugs in palliative care, haloperidol can be administered by multiple routes and can be given without dose alteration in the setting of both renal and hepatic insufficiency. Haloperidol is extensively metabolized in the liver, with CYP3A4 the chief cytochrome oxidase responsible for metabolism. This article will review the pharmacology, pharmacokinetics, and current uses of haloperidol in palliative medicine. There will be an examination of the evidence base for the use of haloperidol in palliative medicine.
Actinobaculum Bacteremia: a Report of 12 Cases
Gomez, Eric, Gustafson, Daniel R., Rosenblatt, Jon E., Patel, Robin , Patel, Robin

Mayo Clinic

Journal of Clinical Microbiology | October 6, 2011 | Volume: 49 | Issue: 12 | Pages: 4311-4313

10.1128/jcm.00798-11 | PMID 21976754 Get It

ABSTRACTActinobaculumspecies are anaerobic Gram-positive rods that have previously been associated with urinary tract infection (UTI) in the elderly. We report 12 patients withActinobaculumbacteremia. Only 40% of blood cultures were clinically considered significant by the treating physicians, but most patients were treated for UTI, suggesting a possible urinary source of bacteremia. Clinicians should be aware of the pathogenic potential ofActinobaculumspp.
Age-related changes in the default mode network are more advanced in Alzheimer disease
Vemuri, Prashanthi , Senjem, Matthew L. , Günter, J, Przybelski, Scott A. , Avula, Ramesh, Petersen, Ronald C. , Jack, Clifford R. , Jones, David T. , Machulda, Mary M. , McDade, Eric , Zeng, Guang‐Zhi , Knopman, David S. , Boeve, Bradley F. , Jack, Clifford R , Vemuri, Prashanthi , Senjem, Matthew L

Mayo Clinic

Neurology | October 5, 2011 | Volume: 77 | Issue: 16 | Pages: 1524-1531

10.1212/wnl.0b013e318233b33d | PMID 21975202 Get It

Cardiac Imaging: Part 2, Normal, Variant, and Anomalous Configurations of the Coronary Vasculature
Young, Phillip M. , Gerber, Thomas C., Williamson, Eric E. , Julsrud, Paul R., Herfkens, Robert J.

Mayo Clinic

American Journal of Roentgenology | September 21, 2011 | Volume: 197 | Issue: 4 | Pages: 816-826

10.2214/ajr.10.7249 | PMID 21940568 Get It